Missing/wrong data?
Log in to edit
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia.
scientific article published on 13 February 2017
Author/s
author: Andrew Intlekofer, Christopher E. Mason, Cem Meydan, Craig B. Thompson
Work details
Publication date
February 13, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.